| Jeffrey Deal, | |
|
3002 Bosshard Dr, Fitchburg, WI 53711-5858 | |
| (608) 445-3946 | |
| Not Available |
| Full Name | Jeffrey Deal |
|---|---|
| Gender | Male |
| Speciality | Registered Nurse |
| Location | 3002 Bosshard Dr, Fitchburg, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134593072 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 11374530 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jeffrey Deal, 3002 Bosshard Dr, Fitchburg, WI 53711-5858 Ph: (608) 445-3946 | Jeffrey Deal, 3002 Bosshard Dr, Fitchburg, WI 53711-5858 Ph: (608) 445-3946 |
News Archive
Exiqon, a leading supplier of high-value gene expression analysis products, today announced the launch of the 3rd generation of miRCURY LNA microRNA Labeling Kit called Hi-Power for labeling of microRNAs for downstream hybridization to microRNA arrays.
In a study published online this week and to be published as a cover story in the July issue of Nature Genetics, Rosetta Genomics' scientists report identification of hundreds of human microRNA genes, including the first report of primate specific microRNAs.
ICF International, a leading provider of consulting services and technology solutions to government and commercial clients, has been awarded a re-compete multiple-award Indefinite Delivery Indefinite Quantity (IDIQ) contract by the U.S. Department of Health and Human Services (HHS), Substance Abuse and Mental Health Services Administration (SAMHSA) to conduct pilot and evaluation studies, statistical analysis, and training and technical assistance (TTA).
GATC Biotech announced today that it has agreed to purchase the PacBio RS platform, a single molecule, real-time (SMRTâ˘) sequencing technology. The new PacBio RS will be the fifth sequencing technology for GATC Biotech. The system is planned for installation in early 2011.
Protalix BioTherapeutics, Inc. announced today that the French regulatory authority has granted an Autorisation Temporaire d'Utilisation (ATU), or Temporary Authorization for Use, for taliglucerase alfa for the treatment of Gaucher disease. An ATU is the regulatory mechanism used by the French Health Products and Safety Agency to make non-approved drugs available to patients in France when a genuine public health need exists.
› Verified 6 days ago
Ms. Tami Mae Schmudlach, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 5164 Anton Dr Apt 105, Fitchburg, WI 53719 Phone: 608-577-5960 | |
Sarah Lynn Brown, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2526 Karakul Ct, Fitchburg, WI 53711 Phone: 408-646-0815 | |
Angela Mae Dailey, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 5602 Guilford Rd Apt 7, Fitchburg, WI 53711 Phone: 920-810-8400 | |
Mr. Kenneth Paul Bichell, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2632 Smithfield Dr, Fitchburg, WI 53719 Phone: 608-273-3486 | |
Mrs. Rebecca Olubumi Barber-thomas, REGISTERED NURSE Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 5696 Claredon Dr, 5696 Claredon Dr, Fitchburg, WI 53711 Phone: 608-288-9212 | |
Tamela Sue Hazel, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2403 E Hill Dr, Fitchburg, WI 53711 Phone: 608-444-2319 |